Age-appropriate vaccination against measles and DPT-3 in India - closing the gaps

BMC Public Health. 2013 Apr 17:13:358. doi: 10.1186/1471-2458-13-358.

Abstract

Background: In 2010, India accounted for 65,500 (47%) of the 139,300 measles-related deaths that occurred globally. Data on the quality of age-appropriate measles vaccination in rural India is sparse. We explored the following issues: (i) What proportion of Indian children were appropriately vaccinated against measles at 9 months of age, and DPT-3 at 4 months? (ii) Which health facilities administered measles vaccine to children prior to 9 months of age and DPT-3 prior to 14 weeks?

Methods: We analyzed data from the 2008 Indian District Level Health Survey (DLHS-3) to determine the extent of age-appropriate measles and DPT-3 vaccinations. Among 192,969 households in the dataset, vaccination cards with detailed records were available for 18,670 children aged between 12 and 23 months.

Results: Among this cohort, 72.4% (13,511 infants) had received the first dose of measles vaccine. Only 30% of vaccinated infants received the measles vaccine at the recommended age of 9 months. Similarly, only 31% of infants in the cohort received DPT-3 vaccine at the recommended age of 14 weeks. About 82% of all prematurely vaccinated children were vaccinated at health sub-centres, ICDS and Pulse Polio centres.

Conclusions: Age-inappropriate vaccination impacts adversely on the effectiveness of India's measles immunisation program due to sub-optimal seroconversion, if premature, and increased vulnerability to vaccine preventable diseases, if delayed. Capacity building approaches to improve age-appropriate vaccination are discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Data Collection
  • Delivery of Health Care / standards*
  • Diphtheria / prevention & control
  • Diphtheria-Tetanus-Pertussis Vaccine*
  • Guideline Adherence*
  • Humans
  • Immunization Programs*
  • India
  • Infant
  • Measles / prevention & control
  • Measles Vaccine*
  • Poliomyelitis / prevention & control
  • Rural Population
  • Tetanus / prevention & control
  • Vaccination* / statistics & numerical data
  • Whooping Cough / prevention & control

Substances

  • Diphtheria-Tetanus-Pertussis Vaccine
  • Measles Vaccine